Prof. GÖKHAN ÖZYİĞİT

Publication Network

Articles 119

1. Does Adding Chemotherapy to Radiotherapy Improve Outcomes in Stage II Nasopharyngeal Carcinoma?

KAHVECIOĞLU A., YILMAZ M. T., MOHAMMADIPOUR S., SARI S. Y., CENGİZ M., GÜLLÜ İ., et al.

Türk Onkoloji Dergisi , vol.40, no.2, pp.112-119, 2025 (ESCI)

2. Translation, Cross-Cultural Adaptation, and Psychometric Validation of the Turkish Version of the "Expanded Prostate Cancer Index Composite (EPIC)" in Prostate Cancer Patients

TİLKİ B., HÜRMÜZ P., YÜCE D., ÖZYİĞİT G., Akyol F.

PROSTATE , no.7, pp.710-718, 2025 (SCI-Expanded)

3. Determining Residents' Concerns About Staying Up to Date: Turkish Society for Radiation Oncology-Young Radiation Oncologists' Cross-Sectional National Survey (TROD/GROG 007)

Yilmaz M. T., KAHVECİOĞLU A., GÜLTEKİN M., ATALAR B., ÖZYİĞİT G., Selek U.

JCO GLOBAL ONCOLOGY , 2025 (ESCI)

4. Stereotactic Ablative Radiotherapy for Bone-Only Oligometastatic Breast Cancer: On a Quest to Find the Optimum Cohort

Yilmaz M. T., Gultekin M., YÜCE SARI S., Kumru T., Kivanc H., ÖZYİĞİT G., et al.

CLINICAL ONCOLOGY , vol.37, 2025 (SCI-Expanded)

5. Analysis of patients with parotid recurrence after parotid-sparing IMRT for nasopharyngeal carcinoma: case series and review of the literature

YÜCE SARI S., Yilmaz M. T., YAZICI G., Mohammadipour S., ÖZYİĞİT G., Gullu İ. H., et al.

STRAHLENTHERAPIE UND ONKOLOGIE , no.12, pp.1057-1065, 2024 (SCI-Expanded, Scopus)

6. Evaluation of Treatment Outcomes of Prostate Cancer Patients With Lymph Node Metastasis Treated With Definitive Radiotherapy

Onal C., Guler O. C., ERPOLAT Ö. P., HÜRMÜZ P., Sutera P., Deek M. P., et al.

CLINICAL NUCLEAR MEDICINE , vol.49, no.8, 2024 (SCI-Expanded)

7. Prostate-Specific Membrane Antigen PET Response Associates with Metastasis-Free Survival After Stereotactic Ablative Radiation in Oligometastatic Prostate Cancer

Sutera P., Deek M. P., Deek R. A., Guler O. C., HÜRMÜZ P., Reyhan M., et al.

ADVANCES IN RADIATION ONCOLOGY , vol.9, no.7, 2024 (ESCI) Sustainable Development

8. Stereotactic radiotherapy for head and neck paragangliomas: How long should we wait for treatment response?

YAZICI G., KAHVECİOĞLU A., YÜCE SARI S., ÖZYİĞİT G., YILDIZ D., CENGİZ M.

Radiotherapy and Oncology , vol.195, 2024 (SCI-Expanded, Scopus)

9. Does Radiotherapy Boost Technique to Positive Internal Mammary Lymph Node in Breast Cancer Matter?

BEDÜK ESEN Ç. S., ÖZYÜREK Y., YÜCE SARI S., GÜLTEKİN M., ÖZYİĞİT G., YILDIZ F.

RADIOTHERAPY AND ONCOLOGY , 2024 (SCI-Expanded)

10. The Impact of Concurrent Chemotherapy on Stage II Nasopharyngeal Carcinoma

Yilmaz M. T., KAHVECİOĞLU A., Mohammadipour S., CENGİZ M., Gullu I., AKSOY S., et al.

RADIOTHERAPY AND ONCOLOGY , 2024 (SCI-Expanded)

11. Stereotactic Ablative Radiotherapy Outcomes for Bone-Only Oligometastatic Breast Cancer

Yilmaz M. T., GÜLTEKİN M., YÜCE SARI S., KUMRU T., Kivanc H., ÖZYİĞİT G., et al.

RADIOTHERAPY AND ONCOLOGY , 2024 (SCI-Expanded)

12. Testicular metastasis in prostate cancer: A rare case of testicular metastasis diagnosed with Ga-68-PSMA and review of the literature

ÖZYİĞİT G., AKDOĞAN B., YILMAZ M. T., GÜNER G., BOZKURT M. F.

JOURNAL OF CLINICAL UROLOGY , vol.17, no.1, pp.79-82, 2024 (ESCI) Sustainable Development

13. Established and new treatment roadmaps for pleural mesothelioma: opinions of the Turkish Collaborative Group

Kaplan M. A., ŞENDUR M. A. N., Cangır A. K., Fırat P., Göker E., Kılıçkap S., et al.

Current Problems in Cancer , vol.47, no.6, 2023 (SCI-Expanded)

14. The Use of EPID-based in vivo Dosimetry for Small Animal Radiation Research

BİLTEKİN F., ÖZYİĞİT G.

Türk Onkoloji Dergisi , vol.38, no.2, pp.201-208, 2023 (ESCI)

15. Treatment outcomes of postoperative ultra-hypofractionated stereotactic body radiotherapy in prostate cancer

ÖZYİĞİT G., Onal C., BEDÜK ESEN Ç. S., TİLKİ B., HÜRMÜZ P.

Urologic Oncology: Seminars and Original Investigations , vol.41, no.5, 2023 (SCI-Expanded)

16. Stereotactic body radiotherapy and tyrosine kinase inhibitors in patients with oligometastatic renal cell carcinoma: a multi-institutional study

Onal C., Oymak E., Guler O. C., TİLKİ B., Yavas G., HÜRMÜZ P., et al.

Strahlentherapie und Onkologie , vol.199, no.5, pp.456-464, 2023 (SCI-Expanded) Sustainable Development

17. The Effect of Video-Based Education on Anxiety of Patients Receiving Stereotactic Radiosurgery and Stereotactic Body Radiation Therapy

BEDÜK ESEN Ç. S., YAZICI G., HÜRMÜZ P., ÖZYİĞİT G., Zorlu F.

JOURNAL OF CANCER EDUCATION , vol.38, no.2, pp.426-430, 2023 (SCI-Expanded, Scopus)

18. Planning and dosimetric evaluation of three total body irradiation techniques: Standard SSD VMAT, Extended SSD VMAT and Extended SSD Field-in-Field

Cananoglu M., HÜRMÜZ P., YEĞİNER M., ÖZYİĞİT G.

RADIATION AND ENVIRONMENTAL BIOPHYSICS , vol.62, no.1, pp.73-81, 2023 (SCI-Expanded)

19. Post-induction lymph node delineation in nasopharyngeal cancer: A single-center experience.

Sari S., YİĞİT E., YAZICI G., GÜLLÜ İ. H., AKSOY S., ÖZYİĞİT G., et al.

Head & neck , vol.45, no.3, pp.612-619, 2023 (SCI-Expanded, Scopus) Sustainable Development

20. Treatment Outcomes of Stereotactic Body Radiotherapy in Patients with Synchronous and Metachronous Oligometastatic Renal Cell Carcinoma

Guler O. C., Oymak E., HÜRMÜZ P., Yavas G., TİLKİ B., Yavas C., et al.

Urologia Internationalis , vol.107, no.2, pp.171-178, 2023 (SCI-Expanded)

21. Quality Assurance Program for Surface-guided Radiation Therapy: A Review of Guidelines

BİLTEKİN F., ÖZYİĞİT G.

Turk Onkoloji Dergisi , vol.38, no.2, pp.246-253, 2023 (ESCI)

22. A new perspective on the future of Turkish Society for Radiation Oncology: Young Radiation Oncologists Group (TROD/GROG 001)

Kaplan S. O., ATALAR B., Akboru M. H., TİLKİ B., Kanat S., YÜCEL S., et al.

Reports of Practical Oncology and Radiotherapy , vol.28, no.1, pp.88-92, 2023 (ESCI)

23. Evaluation of the Radiation Oncologists’ Awareness and Needs about Geriatric Oncology: TROD-13-001 Study

Sert F., Metcalfe E., Erkal E. Y., Bakkal B. H., ÖZYİĞİT G., Alço G.

Turk Onkoloji Dergisi , vol.38, no.3, pp.295-300, 2023 (ESCI)

24. Preclinical Dosimetry for Small Animal Radiation Research in Proton Therapy: A Feasibility Study

Biltekin F., Bäumer C., Esser J., Ghanem O., Özyiğit G., Timmermann B.

International Journal of Particle Therapy , vol.10, no.1, pp.13-22, 2023 (ESCI)

25. Every other day stereotactic radiation therapy for the treatment of uveal melanoma decreases toxicity

YAZICI G., KIRATLI H., ÖZYİĞİT G., Sari S., Elmali A., Yilmaz M. T., et al.

RADIOTHERAPY AND ONCOLOGY , vol.176, pp.39-45, 2022 (SCI-Expanded, Scopus)

26. Bone-only oligometastatic renal cell carcinoma patients treated with stereotactic body radiotherapy: a multi-institutional study

Onal C., Guler O. C., HÜRMÜZ P., YAVAŞ G., TİLKİ B., Oymak E., et al.

STRAHLENTHERAPIE UND ONKOLOGIE , vol.198, no.10, pp.940-948, 2022 (SCI-Expanded) Sustainable Development

27. Turkish translation and validation of the Xerostomia Inventory

Sari S., Yilmaz M. T., ELMALI A., KILIÇ L., YÜCE D., ÖZYİĞİT G., et al.

ARCHIVES OF RHEUMATOLOGY , vol.37, pp.351-360, 2022 (SCI-Expanded, Scopus, TRDizin)

28. The role of stereotactic body radiotherapy in switching systemic therapy for patients with extracranial oligometastatic renal cell carcinoma

Onal C., HÜRMÜZ P., Guler O. C., YAVAŞ G., TİLKİ B., Oymak E., et al.

CLINICAL & TRANSLATIONAL ONCOLOGY , vol.24, no.8, pp.1533-1541, 2022 (SCI-Expanded)

29. Stereotactic body radiotherapy optimization to reduce the risk of carotid blowout syndrome using normal tissue complication probability objectives

Szalkowski G., Karakas Z., CENGİZ M., Schreiber E., Das S., YAZICI G., et al.

JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS , vol.23, 2022 (SCI-Expanded, Scopus) Sustainable Development

30. The Promise of Metastasis-Directed Therapy for Oligometastatic Prostate Cancer: Going Beneath the Surface with Molecular Imaging

Sutera P., Phillips R. M., Deek M., ÖZYİĞİT G., Onal C., Tran P. T.

JOURNAL OF NUCLEAR MEDICINE , vol.63, no.3, pp.339-341, 2022 (SCI-Expanded)

31. Do grape and black mulberry molasses have an effect on oral mucositis and quality of life in patients with head and neck cancer?

Sari S., BEDÜK ESEN Ç. S., YAZICI G., YÜCE D., CENGİZ M., ÖZYİĞİT G.

SUPPORTIVE CARE IN CANCER , vol.30, no.1, pp.327-336, 2022 (SCI-Expanded, Scopus) Sustainable Development

32. Stereotactic body radiotherapy boost in patients with cervical cancer

GÜLTEKİN M., Yilmaz M. T., Sari S., YILDIZ D., ÖZYİĞİT G., YILDIZ F.

JOURNAL OF OBSTETRICS AND GYNAECOLOGY , vol.42, no.7, pp.3033-3040, 2022 (SCI-Expanded)

33. Patient-specific tumor and respiratory monitoring phantom design for quality controls of stereotactic ablative body radiotherapy in lung cancer cases

Erdogan T., FİDAN U., ÖZYİĞİT G.

PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS , vol.90, pp.40-49, 2021 (SCI-Expanded) Sustainable Development

34. Oligometastatic Bone Disease in Castration-Sensitive Prostate Cancer Patients Treated With Stereotactic Body Radiotherapy Using Ga-68-PSMA PET/CT TROD 09-004 Study

Onal C., ÖZYİĞİT G., Akgun Z., Atalar B., Igdem S., Oymak E., et al.

CLINICAL NUCLEAR MEDICINE , vol.46, no.6, pp.465-470, 2021 (SCI-Expanded) Sustainable Development

35. Gemcitabine based trimodality treatment in patients with muscle invasive bladder cancer: May neutrophil lymphocyte and platelet lymphocyte ratios predict outcomes?

HÜRMÜZ P., ÖZYİĞİT G., Kilickap S., BEDÜK ESEN Ç. S., AKDOĞAN B., Ozen H., et al.

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS , vol.39, no.6, 2021 (SCI-Expanded)

36. Radiosensitization induced by zinc-doped hydroxyapatite nanoparticles in breast cancer cells

Yedekci Y., Gedik E., EVİS Z., Dogan L., ÖZYİĞİT G., Gürkaynak M.

International Journal of Applied Ceramic Technology , vol.18, no.3, pp.563-572, 2021 (SCI-Expanded) Sustainable Development

37. Factors affecting post-treatment radiation-induced lung disease in patients receiving stereotactic body radiotherapy to lung

HÜRMÜZ P., CENGİZ M., Esen C. S. B., Yedekci Y., YILDIZ Z., ÖZYİĞİT G., et al.

Radiation and Environmental Biophysics , vol.60, pp.87-92, 2021 (SCI-Expanded) Sustainable Development

38. Novel Technological Aspects of Radiation Therapy in Head and Neck Cancer

Jeremic B., Kiladze I., ÖZYİĞİT G., Filipovic N., Dubinsky P.

TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY , vol.36, no.2, pp.236-246, 2021 (ESCI)

39. Does Intravesical Prostatic Protrusion Affect Oncological Outcomes and Toxicity in Prostate Cancer Patients Receiving Definitive Radiotherapy?

HÜRMÜZ P., BEDÜK ESEN Ç. S., Unal E., KARÇAALTINCABA M., ÖZYİĞİT G., AKYOL H. F.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.31, no.1, pp.1-7, 2021 (SCI-Expanded)

40. Systemic Therapy in Recurrent or Metastatic Squamous Cell Head and Neck Cancer

Kiladze I., ÖZYİĞİT G., Dubinsky P., FilipoviC N., Jeremic B.

TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY , vol.36, pp.519-528, 2021 (ESCI)

41. Neoadjuvant Radiotherapy in Rectal Cancer: A Single Center Experience

HÜRMÜZ P., TİLKİ B., CENGİZ M., YILDIZ F., ÖZYİĞİT G., EROL T., et al.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.31, no.3, pp.178-184, 2021 (SCI-Expanded) Sustainable Development

42. Does Internal Mammary Node Irradiation for Breast Cancer Make a Significant Difference to the Diameter of the Internal Mammary Artery? Correlation with Computed Tomography

DURHAN G., ERDEMİR A. G., Sari S., GÜLTEKİN M., KARAKAYA KARABULUT J., GÜLSÜN AKPINAR M., et al.

BREAST CARE , vol.15, no.6, pp.635-641, 2020 (SCI-Expanded)

43. Hyaluronic acid spacer in focal prostate reirradiation: A single centre experience

ÖZYİĞİT G., HÜRMÜZ P., AKINCI D., Esen S. C. B., YILMAZ M., AKDOĞAN B., et al.

CANCER RADIOTHERAPIE , vol.24, no.8, pp.805-811, 2020 (SCI-Expanded) Sustainable Development

44. Treatment outcomes of metastasis-directed treatment using(68)Ga-PSMA-PET/CT for oligometastatic or oligorecurrent prostate cancer: Turkish Society for Radiation Oncology group study (TROD 09-002)

HÜRMÜZ P., Onal C., ÖZYİĞİT G., Igdem S., Atalar B., Sayan H., et al.

STRAHLENTHERAPIE UND ONKOLOGIE , vol.196, no.11, pp.1034-1043, 2020 (SCI-Expanded) Sustainable Development

45. Stereotactic body radiotherapy in patients with early-stage non-small cell lung cancer: Does beam-on time matter?

HÜRMÜZ P., CENGİZ M., ÖZYİĞİT G., Akkas E. A., YÜCE D., YILMAZ M. T., et al.

JAPANESE JOURNAL OF CLINICAL ONCOLOGY , vol.50, no.10, pp.1182-1187, 2020 (SCI-Expanded)

46. Second Malignancies after Radiation Therapy for Prostate Cancer

Sari S., ELMALI A., Arslan S., ÖZYİĞİT G.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS , vol.107, no.2, pp.387-388, 2020 (SCI-Expanded) Sustainable Development

47. Outcome of Elderly Nasopharyngeal Carcinoma Patients: A Single Center Study

Basaran H., CENGİZ M., YAZICI G., Ozdemir Y., SÜTAY SÜSLÜ N., GÜLLÜ İ. H., et al.

EUROPEAN JOURNAL OF THERAPEUTICS , vol.26, no.2, pp.129-134, 2020 (ESCI)

48. Optimal Dose of Cisplatin (CDDP) Given Concurrently with Radiotherapy (RT) in Locally Advanced Squamous Cell Head and Neck Cancer (SQC HNC)

Jeremic B., Dubinsky P., Jeremic M., Kiladze I., ÖZYİĞİT G.

TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY , vol.35, no.2, pp.237-241, 2020 (ESCI)

49. Validation of the EORTC-QLQ-HN35 Questionnaire in Turkish Head and Neck Cancer Patients

YÜCE SARI S., BEDÜK ESEN Ç. S., YÜCE D., CENGİZ M., ÖZYİĞİT G., YAZICI G.

TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY , vol.35, no.2, pp.144-149, 2020 (ESCI, Scopus, TRDizin)

50. Dosimetric comparison of three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for left-sided chest wall and lymphatic irradiation

Kivanc H., GÜLTEKİN M., Gurkaynak M., ÖZYİĞİT G., YILDIZ F.

JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS , vol.20, no.12, pp.36-44, 2019 (SCI-Expanded)

51. Outcome of loco-regional radiotherapy in metastatic castration-resistant prostate cancer patients treated with abiraterone acetate

Yildirim B. A., Onal C., Kose F., Oymak E., Sedef A. M., Besen A. A., et al.

STRAHLENTHERAPIE UND ONKOLOGIE , vol.195, no.10, pp.872-881, 2019 (SCI-Expanded) Sustainable Development

52. Treatment outcomes of prostate cancer patients with Gleason score 8-10 treated with definitive radiotherapy

ÖZYİĞİT G., Onal C., Igdem S., Alicikus Z. A., Iribas A., Akin M., et al.

STRAHLENTHERAPIE UND ONKOLOGIE , vol.195, no.10, pp.882-893, 2019 (SCI-Expanded) Sustainable Development

53. Radiotherapy After Skin-Sparing Mastectomy and Implant-Based Breast Reconstruction

Sari S., Guler O. C., GÜLTEKİN M., Yildirim B. A., Onal C., ÖZYİĞİT G., et al.

CLINICAL BREAST CANCER , vol.19, no.5, 2019 (SCI-Expanded) Sustainable Development

54. Integration of 68Ga-PSMA-PET/CT in Radiotherapy Planning for Prostate Cancer Patients

Onal C., Torun N., Akyol F., Guler O. C., HÜRMÜZ P., Yildirim B. A., et al.

CLINICAL NUCLEAR MEDICINE , vol.44, no.9, 2019 (SCI-Expanded) Sustainable Development

55. Feasibility study of an electronic portal imaging based in vivo dose verification system for prostate stereotactic body radiotherapy

Yedekci Y., Biltekin F., Özyiğit G.

Physica Medica , vol.64, pp.204-209, 2019 (SCI-Expanded)

56. Prognostic significance of castrate testosterone levels for patients with intermediate and high risk prostate cancer

ÖZYİĞİT G., HÜRMÜZ P., YÜCE D., Akyol F.

WORLD JOURNAL OF CLINICAL ONCOLOGY , vol.10, no.8, pp.283-292, 2019 (ESCI) Sustainable Development

57. The hematologic parameters in metastatic castration-resistant prostate cancer patients treated with abiraterone acetate

Onal C., Sedef A. M., Kose F., Oymak E., Guler O. C., Sumbul A. T., et al.

FUTURE ONCOLOGY , vol.15, no.13, pp.1469-1479, 2019 (SCI-Expanded) Sustainable Development

58. Sub-Castrate Testosterone Nadir and Clinical Outcomes in Intermediate or High-Risk Localized Prostate Cancer

HÜRMÜZ P., ÖZYİĞİT G.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS , vol.104, no.1, pp.224-225, 2019 (SCI-Expanded) Sustainable Development

59. Feasibility of novel in vivo EPID dosimetry system for linear accelerator quality control tests

BİLTEKİN F., Yedekci Y., ÖZYİĞİT G.

Australasian Physical and Engineering Sciences in Medicine , 2019 (SCI-Expanded)

60. Current Status and Future Aspects of Stereotactic Body Radiotherapy and Immunotherapy in the Management of Recurrent Head and Neck Cancer

ÖZYİĞİT G., YÜCE SARI S., YAZICI G., CENGİZ M.

TURK ONKOLOGI DERGISI-TURKISH JOURNAL OF ONCOLOGY , vol.34, no.4, pp.313-320, 2019 (ESCI) Sustainable Development

61. Neoadjuvant Chemotherapy Improves Survival in Patients with Locally Advanced Nasopharyngeal Carcinoma

Basaran H., CENGİZ M., YAZICI G., Susulu N., AKSOY S., HOŞAL A. Ş., et al.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.29, no.3, pp.176-185, 2019 (SCI-Expanded)

62. Fitting NTCP models to SBRT dose and carotid blowout syndrome data

Mavroidis P., Grimm J., CENGİZ M., Das S., Tan X., YAZICI G., et al.

MEDICAL PHYSICS , vol.45, no.10, pp.4754-4762, 2018 (SCI-Expanded, Scopus)

63. The Synergistic Effect of Immune Checkpoint Blockade and Radiotherapy in Recurrent/Metastatic Sinonasal Cancer

YAZICI G., GÜLLÜ İ. H., CENGİZ M., ELMALI DOĞAN A., YILMAZ M. T., AKSOY S., et al.

Cureus , vol.10, pp.3519, 2018 (ESCI)

64. A Phase II Study of Stereotactic Body Radiation Therapy and Stereotactic Body Proton Therapy for High-risk Medically Inoperable Early-stage Non-small Cell Lung Cancer

HÜRMÜZ P., ÖZYİĞİT G.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS , vol.101, no.3, pp.744-745, 2018 (SCI-Expanded)

65. Baş-Boyun Kanserlerinde Reirradyasyon

YÜCE SARI S., ÖZYİĞİT G.

Türkiye Klinikleri Radyasyon Onkolojisi Özel Dergisi , vol.11, no.2, pp.160-169, 2018 (Peer-Reviewed Journal)

66. Investigating the surface dose contribution of intrafractional kV imaging in CyberKnife-based stereotactic radiosurgery

Canbolat A., Zorlu F., HÜRMÜZ P., YEĞİNER M., ÖZYİĞİT G.

MEDICAL DOSIMETRY , vol.42, no.4, pp.304-309, 2017 (SCI-Expanded)

67. Stereotactic Radiosurgery and Fractionated Stereotactic Radiation Therapy for the Treatment of Uveal Melanoma

YAZICI G., KIRATLI H., ÖZYİĞİT G., Sari S., CENGİZ M., TARLAN B., et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS , vol.98, no.1, pp.152-158, 2017 (SCI-Expanded, Scopus)

68. Reirradiation of Pediatric Tumors Using Hypofractionated Stereotactic Radiotherapy.

GULTEKIN M., CENGIZ M., SEZEN D., ZORLU F., YILDIZ F., Yazici G., et al.

Technology in cancer research & treatment , vol.16, pp.195-202, 2017 (SCI-Expanded, Scopus)

69. Validation of the EORTC QLQ-OES18 Questionnaire in Patients Treated with Radiotherapy

SARI S., YAZICI G., YÜCE D., CENGİZ M., ÖZYİĞİT G.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.27, no.3, pp.178-184, 2017 (SCI-Expanded)

70. Yüksek Risk Prostat Kanserinin Tedavisinde Radyoterapi

YÜCE SARI S., ÖZYİĞİT G.

Türkiye Klinikleri Radyasyon Onkolojisi Özel Dergisi , vol.3, no.2, pp.91-96, 2017 (Peer-Reviewed Journal) Sustainable Development

71. The effect of glutamine and arginine-enriched nutritional support on quality of life in head and neck cancer patients treated with IMRT

Sari S., YAZICI G., YÜCE D., KARABULUT E., CENGİZ M., ÖZYİĞİT G.

CLINICAL NUTRITION ESPEN , vol.16, pp.30-35, 2016 (ESCI, Scopus) Sustainable Development

72. The effect of leg position on the dose distribution of intracavitary brachytherapy for cervical cancer: 3D computerised tomography plan evaluation and in vivo dosimetric study

CENGİZ M., Colak F., YILDIZ D., DOĞAN A., ÖZYİĞİT G., YILDIZ F., et al.

JOURNAL OF RADIOTHERAPY IN PRACTICE , vol.15, no.4, pp.341-345, 2016 (ESCI) Sustainable Development

73. Evaluation of Photoneutron Dose Measured by Bubble Detectors in Conventional Linacs and Cyberknife Unit: Effective Dose and Secondary Malignancy Risk Estimation

BİLTEKİN F., YEĞİNER M., ÖZYİĞİT G.

TECHNOLOGY IN CANCER RESEARCH & TREATMENT , vol.15, no.4, pp.560-565, 2016 (SCI-Expanded) Sustainable Development

74. The dosimetric impact of implants on the spinal cord dose during stereotactic body radiotherapy

YAZICI G., SARI S., YEDEKÇİ F. Y., Yucekul A., BIRGI S. D., DEMIRKIRAN G., et al.

RADIATION ONCOLOGY , vol.11, 2016 (SCI-Expanded, Scopus)

75. Dosimetric and Mechanical Stability of CyberKnife Robotic Radiosurgery Unit: 5 Years’ Clinical Experience

BİLTEKİN F., YAZICI G., CENGİZ M., DOĞAN A., Ünlü B., YEĞİNER M., et al.

Turkish Journal of Oncology , vol.31, pp.45-50, 2016 (Peer-Reviewed Journal)

76. Robotic Stereotactic Body Radiation Therapy in Patients With Recurrent or Metastatic Abdominopelvic Tumors: A Single Institute Experience

Sezen D., GÜRKAYNAK H. M., GÜLTEKİN M., CENGİZ M., YILDIZ F., ZORLU A. F., et al.

TECHNOLOGY IN CANCER RESEARCH & TREATMENT , vol.15, no.1, pp.203-211, 2016 (SCI-Expanded, Scopus)

77. High-grade glioma in children and adolescents: a single-center experience

YAZICI G., ZORLU F., CENGİZ M., ÖZYİĞİT G., Eren G., YÜCE D., et al.

CHILDS NERVOUS SYSTEM , vol.32, no.2, pp.291-297, 2016 (SCI-Expanded, Scopus)

78. Evaluation of MLC leaf positioning accuracy for static and dynamic IMRT treatments using DAVID in vivo dosimetric system

Karagöz G., ZORLU A. F., YEĞİNER M., YILDIZ D., ÖZYİĞİT G.

JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS , vol.17, no.2, pp.14-23, 2016 (SCI-Expanded)

79. Dosimetric and Mechanical Stability of CyberKnife Robotic Radiosurgery Unit: 5 Years’xx Clinical Experience

BİLTEKİN F., YAZICI G., CENGİZ M., dogan a., ÜNLÜ b., YEĞİNER M., et al.

Türk Onkoloji Dergisi , vol.31, pp.45-50, 2016 (Scopus)

80. Lokal İleri Evre Küçük Hücreli Dışı Akciğer Kanserinde Primer Kemoradyoterapi

ÖZYİĞİT G., YÜCE SARI S.

Türkiye Klinikleri Akciğer Kanseri Özel , 2016 (Peer-Reviewed Journal) Sustainable Development

81. Investigating in-field and out-of-field neutron contamination in high-energy medical linear accelerators based on the treatment factors of field size, depth, beam modifiers, and beam type

BİLTEKİN F., YEĞİNER M., ÖZYİĞİT G.

PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS , vol.31, no.5, pp.517-523, 2015 (SCI-Expanded)

82. PREVENTION OF RADIATION-INDUCED RETINOPATHY WITH AMIFOSTINE IN WISTAR ALBINO RATS

Yildirim B. A., Cetin E., Topkan E., ÖZYİĞİT G., CENGİZ M., Surucu S., et al.

RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES , vol.35, no.7, pp.1458-1464, 2015 (SCI-Expanded)

83. Three Dimensional Conformal Radiotherapy and Androgen Deprivation Therapy in Patients with Clinically Localized Prostate Cancer; Hacettepe University Experience

ÖZDEMİR Y., Akyol F., ÖZYİĞİT G., HÜRMÜZ P., Onal C., Selek U., et al.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.25, no.2, pp.107-117, 2015 (SCI-Expanded)

84. Daily workflow and workload of radiation oncology specialists in Turkey

AKMAN F., Kamer S., Onal C., Agaoglu F., Guney Y., Hicsonmez A., et al.

TURK ONKOLOGI DERGISI-TURKISH JOURNAL OF ONCOLOGY , vol.30, no.4, pp.204-211, 2015 (ESCI)

85. Review of Current Status of Radiotherapy Facilities and Assessment of Required Time for Radiotherapy Delivery Workflow in Turkey: On Behalf of Turkish Society for Radiation Oncology

AKMAN F., Onal C., Kamer S., Agaoglu F., Guney Y., Hicsonmez A., et al.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.25, no.4, pp.245-253, 2015 (SCI-Expanded)

86. Hypofractionated stereotactic reirradiation for recurrent glioblastoma

YAZICI G., CENGİZ M., ÖZYİĞİT G., Eren G., YILDIZ F., Akyol F., et al.

JOURNAL OF NEURO-ONCOLOGY , vol.120, no.1, pp.117-123, 2014 (SCI-Expanded, Scopus)

87. Robotic Stereotactic Radiosurgery in Patients with Nasal Cavity and Paranasal Sinus Tumors

ÖZYİĞİT G., CENGİZ M., HÜRMÜZ P., YAZICI G., GÜLTEKİN M., Akyol F., et al.

TECHNOLOGY IN CANCER RESEARCH & TREATMENT , vol.13, no.5, pp.409-413, 2014 (SCI-Expanded, Scopus)

88. Current role of modern radiotherapy techniques in the management of breast cancer

ÖZYİĞİT G., GÜLTEKİN M.

WORLD JOURNAL OF CLINICAL ONCOLOGY , vol.5, no.3, pp.425-439, 2014 (ESCI) Sustainable Development

89. Comparison of Chest Wall and Lymphatic Radiotherapy Techniques in Patients with Left Breast Carcinoma

GÜLTEKİN M., Karabuga M., YILDIZ F., ÖZYİĞİT G., CENGİZ M., Zorlu F., et al.

JOURNAL OF BREAST HEALTH , vol.10, no.2, pp.106-110, 2014 (ESCI)

90. A View from Young Oncologists on Clinical Trials in Turkey: Obstacles and Solution Proposals

Akman T., TANRIVERDİ Ö., Ozturk M. A., Petekkaya I., Bakkal H., Sonmez O. U., et al.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.24, no.3, pp.195-201, 2014 (SCI-Expanded)

91. RADIOTHERAPY IN THE TREATMENT OF ELDERLY GLIOBLASTOMA PATIENTS

HÜRMÜZ P., ÖZYİĞİT G., CENGİZ M., YÜCE D., GÜLTEKİN M., YAZICI G., et al.

TURKISH JOURNAL OF GERIATRICS-TURK GERIATRI DERGISI , vol.17, no.2, pp.134-137, 2014 (SCI-Expanded, SSCI, Scopus, TRDizin)

92. Evaluation of secondary malignancy risk due to the whole body computerized tomography simulation in radiotherapy facilities Radyoterapi ünitelerinde bilgisayarli{dotless} tomografi simülasyonuna baǧli{dotless} i̇kincil kanser riski deǧerlendirmesi

BİLTEKİN F., YILDIZ D., ÖZYİĞİT G.

UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi , vol.23, no.4, pp.250-253, 2013 (SCI-Expanded)

93. A simple strategy to decrease fatal carotid blowout syndrome after stereotactic body reirradiaton for recurrent head and neck cancers

YAZICI G., Sanli T. Y., CENGİZ M., YÜCE D., GÜLTEKİN M., HÜRMÜZ P., et al.

RADIATION ONCOLOGY , vol.8, 2013 (SCI-Expanded, Scopus) Sustainable Development

94. Determination of gonad doses during robotic stereotactic radiosurgery for various tumor sites

Zorlu F., Dugel G., ÖZYİĞİT G., HÜRMÜZ P., CENGİZ M., YILDIZ F., et al.

MEDICAL PHYSICS , vol.40, no.4, 2013 (SCI-Expanded)

95. Robotic Stereotactic Radiosurgery in Patients with Unresectable Glomus Jugulare Tumors

HÜRMÜZ P., CENGİZ M., ÖZYİĞİT G., YAZICI G., AKYOL F., YILDIZ F., et al.

TECHNOLOGY IN CANCER RESEARCH & TREATMENT , vol.12, no.2, pp.109-113, 2013 (SCI-Expanded, Scopus)

96. Robotic stereotactic body radiotherapy in the treatment of sinonasal mucosal melanoma: Report of four cases

ÖZYİĞİT G., CENGİZ M., YAZICI G., YILDIZ F., Sezen D., YILDIZ D., et al.

HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK , vol.35, no.3, 2013 (SCI-Expanded, Scopus)

97. Salvage Stereotactic Body Radiosurgery in the Management of Recurrent Gynecological Cancer

YAZICI G., CENGİZ M., ÖZYİĞİT G., Yavas G., Ayhan A., Gurkaynak M., et al.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.23, no.1, pp.7-12, 2013 (SCI-Expanded, Scopus, TRDizin)

98. Determination of the Planning Target Volume Margin by the Use of kv Portal Imaging and kvCone Beam Computerized Tomography

YAZICI G., YEĞİNER M., Atamel M., HÜRMÜZ P., GÜLTEKİN M., CENGİZ M., et al.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.23, no.4, pp.254-259, 2013 (SCI-Expanded)

99. Comparison of FIGO 1988 and 2009 staging systems for endometrial carcinoma

GÜLTEKİN M., YILDIZ F., ÖZYİĞİT G., Beyaz H., HAYRAN K. M., Kose F., et al.

MEDICAL ONCOLOGY , vol.29, no.4, pp.2955-2962, 2012 (SCI-Expanded)

100. Evaluation of the effects of mediastinal radiation therapy on autonomic nervous system

Hoca A., YILDIZ M., ÖZYİĞİT G.

MEDICAL ONCOLOGY , vol.29, no.5, pp.3581-3586, 2012 (SCI-Expanded)

101. Health-related quality of life in high-grade glioma patients: a prospective single-center study

Yavas C., Zorlu F., ÖZYİĞİT G., Gurkaynak M., YAVAŞ G., YÜCE D., et al.

SUPPORTIVE CARE IN CANCER , vol.20, no.10, pp.2315-2325, 2012 (SCI-Expanded)

102. Prospective assessment of health-related quality of life in patients with low-grade glioma A single-center experience

Yavas C., Zorlu F., ÖZYİĞİT G., Gurkaynak M., YAVAŞ G., YÜCE D., et al.

SUPPORTIVE CARE IN CANCER , vol.20, no.8, pp.1859-1868, 2012 (SCI-Expanded) Sustainable Development

103. High daily fraction dose external radiotherapy for T1 glottic carcinoma: Treatment results and prognostic factors

GÜLTEKİN M., Ozyar E., CENGİZ M., ÖZYİĞİT G., HAYRAN K. M., Hosal S., et al.

HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK , vol.34, no.7, pp.1009-1014, 2012 (SCI-Expanded)

104. DOES SACRIFICING THE DEEP LOBE OF PAROTID GLAND PREVENT MARGINAL MISS? IN REGARD TO CHEN ET AL. (INT J RADIAT ONCOL BIOL PHYS 2011;80:1423-1429)

YAZICI G., CENGİZ M., YILDIZ F., ÖZYİĞİT G.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS , vol.82, no.4, pp.1321-1322, 2012 (SCI-Expanded)

105. Comparison of intracavitary brachytherapy and stereotactic body radiotherapy dose distribution for cervical cancer

CENGİZ M., DOĞAN A., ÖZYİĞİT G., Erturk E., YILDIZ F., SELEK U., et al.

BRACHYTHERAPY , vol.11, no.2, pp.125-129, 2012 (SCI-Expanded) Sustainable Development

106. Utility of "Over D1" or D1 Nodal Dissections in Predicting Outcome of Patients with Gastric Adenocarcinoma Treated with Postoperative Concurrent Chemoradiotherapy

SELEK U., Zorlu F., ÖZYİĞİT G., HÜRMÜZ P., YALÇIN Ş., CENGİZ M.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.22, no.4, pp.233-238, 2012 (SCI-Expanded)

107. A RETROSPECTIVE COMPARISON OF ROBOTIC STEREOTACTIC BODY RADIOTHERAPY AND THREE-DIMENSIONAL CONFORMAL RADIOTHERAPY FOR THE REIRRADIATION OF LOCALLY RECURRENT NASOPHARYNGEAL CARCINOMA

ÖZYİĞİT G., CENGİZ M., YAZICI G., YILDIZ F., Gurkaynak M., Zorlu F., et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS , vol.81, no.4, 2011 (SCI-Expanded, Scopus)

108. The Effect of Vitamin D Prophylaxis on Radiation Induced Pulmonary Damage

YAZICI G., YILDIZ F., Iskit A., Erdemli E., Surucu S., FIRAT P., et al.

JOURNAL OF RADIATION RESEARCH , vol.52, no.5, pp.616-621, 2011 (SCI-Expanded, Scopus)

109. SALVAGE REIRRADIATON WITH STEREOTACTIC BODY RADIOTHERAPY FOR LOCALLY RECURRENT HEAD-AND-NECK TUMORS

CENGİZ M., ÖZYİĞİT G., YAZICI G., DOĞAN A., YILDIZ F., Zorlu F., et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS , vol.81, no.1, pp.104-109, 2011 (SCI-Expanded, Scopus)

110. Management of Ductal Carcinoma In Situ Patients Receiving Postoperative Radiotherapy after Breast Conserving Surgery: Hacettepe Experience

ÖZYİĞİT G., ÜLGER Ş., YILDIZ F., Gurkaynak M.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.21, no.1, pp.19-25, 2011 (SCI-Expanded)

111. The Efficiency and Toxicity of Hemithoracic Radiotherapy After Extra Pleural Pneumonectomy in Malign Pleural Mesothelioma

HÜRMÜZ P., Akyol F., SELEK U., ÖZYİĞİT G., DOĞAN R., Ozdemir N., et al.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.20, no.1, pp.20-26, 2010 (SCI-Expanded)

112. THE RESULTS OF SURGERY, WITH OR WITHOUT RADIOTHERAPY, FOR PRIMARY SPINAL MYXOPAPILLARY EPENDYMOMA: A RETROSPECTIVE STUDY FROM THE RARE CANCER NETWORK

Pica A., Miller R., Villa S., Kadish S. P., ANACAK Y., Abusaris H., et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS , vol.74, no.4, pp.1114-1120, 2009 (SCI-Expanded) Sustainable Development

113. Percent positive axillary involvement predicts for the development of brain metastasis in high-risk patients with nonmetastatic breast cancer receiving post-mastectomy radiotherapy

Atahan I. L., ÖZYİĞİT G., YILDIZ F., Gurkaynak M., Selek U., Sari S., et al.

BREAST JOURNAL , vol.14, no.3, pp.245-249, 2008 (SCI-Expanded) Sustainable Development

114. Percent positive axillary lymph node metastasis predicts survival in patients with non-metastatic breast cancer

Atahan I. L., YILDIZ F., ÖZYİĞİT G., Sari S., Gurkaynak M., Selek U., et al.

ACTA ONCOLOGICA , vol.47, no.2, pp.232-238, 2008 (SCI-Expanded)

115. Boost dose back again in elderly

GÜLTEKİN M., SELEK U., ÖZYİĞİT G., CENGİZ M., Yavas O., YILDIZ F.

JOURNAL OF CLINICAL ONCOLOGY , vol.25, no.36, pp.5843-5844, 2007 (SCI-Expanded)

116. Is mastectomy superior to breast-conserving treatment for young women?: In regard to Coulombe et al. (Int J Radiat Oncol Biol Phys 2007;67 : 1282-1290)

Yazici G., Selek U., Yildiz F., Ozyigit G., Cengiz M.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS , vol.69, no.2, pp.640, 2007 (SCI-Expanded)

117. Histomorphological and immunohistochemical evaluation of postradiotherapy prostate needle biopsies

Saglam A., Ozyigit G., Aksoy F., Ruacan S., Sungur A.

VIRCHOWS ARCHIV , vol.451, no.2, pp.409, 2007 (SCI-Expanded)

118. Comment on "cranial location of level II lymph nodes in laryngeal cancer: Implications for elective nodal target volume delineation": In regard to Braam et al. (Int J Radiat Oncol Biol Phys 2007;67.462-468)

Ozyigit G., Selek U., Cengiz M., Yildiz F.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS , vol.68, no.5, pp.1582-1583, 2007 (SCI-Expanded)

119. Use of CT simulation for treatment of cervical cancer to assess the adequacy of lymph node coverage of conventional pelvic fields based on bony landmarks: In regard to Finlay et al. (Int J Radiat Oncol Biol Phys 2006;64 : 205-209)

Yazici G., Yildiz F., Cengiz M., Ozyigit G., Selek U., GENC M., et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS , vol.65, no.5, pp.1594, 2006 (SCI-Expanded)

Papers Presented at Peer-Reviewed Scientific Conferences 108

1. Reirradiation With Stereotactic Ablative Radiotherapy In Recurrent Head And Neck Cancers

YİĞİT E., Yilmaz M. T., KAHVECİOĞLU A., YEDEKÇİ F. Y., YÜCE SARI S., CENGİZ M., et al.

9th International Congress on Innovative Approaches in Head and Neck Oncology (ICHNO), Barcelona, Spain, 21 - 23 March 2024, (Summary Text)

2. Reirradiation with Stereotactic Ablative Radiotherapy in Recurrent Nasopharyngeal Carcinoma

Yilmaz M. T., YİĞİT E., KAHVECİOĞLU A., YEDEKÇİ F. Y., YÜCE SARI S., CENGİZ M., et al.

9th International Congress on Innovative Approaches in Head and Neck Oncology (ICHNO), Barcelona, Spain, 21 - 23 March 2024, (Summary Text)

3. Baş-boyun Radyoterapisi Sonrası Görülen Ağız Kuruluğunda Parotis Kök Hücrelerinin Önemi.

YÜCE SARI S., ELMALI A., YILMAZ M. T., YEDEKÇİ F. Y., YÜCE D., ÖZYİĞİT G., et al.

UROK 2021, Antalya, Turkey, 26 - 30 November 2021, (Summary Text)

4. 3 boyutlu yazıcı kullanılarak bolus üretimi: baskı parametrelerinin dozimetrik etkisinin araştırılması

BİLTEKİN F., CANANOĞLU M., ASLAN A., YAZICI G., AKYOL H. F., ÖZYİĞİT G.

14. Ulusal Radyasyon Onkolojisi Kongresi, Antalya, Turkey, 26 - 30 November 2021, pp.211, (Summary Text)

5. Kraniyospinal ışınlamalarında üç boyutlu optimizasyon tabanlı tedavi planlama tekniği: fizibilite çalışması

BİLTEKİN F., CANANOĞLU M., KARAAK C., ZORLU A. F., YAZICI G., ÖZYİĞİT G.

14. Ulusal Radyasyon Onkolojisi Kongresi, Antalya, Turkey, 26 - 30 November 2021, pp.156-157, (Summary Text)

6. Dozimetrik ve mekanik kalite kontol testlerinde epid-tabanli üç boyutlu in-vivo dozimetre sisteminin kullanilabilirliği

BİLTEKİN F., YEDEKÇİ F. Y., ÖZYİĞİT G.

14. Ulusal Radyasyon Onkolojisi Kongresi, Antalya, Turkey, 26 November 2021, pp.220-221, (Summary Text)

7. PO-1863 3D in-vivo dosimetry for novel inverse optimized 3D-CRT technique in craniospinal irradiation

BİLTEKİN F., YAZICI G., ÖZYİĞİT G.

ESTRO 2021, Madrid, Spain, 28 - 31 August 2021, vol.161, pp.1587-1588, (Summary Text)

8. PO-1627 Dosimetric characterization of 3D-printed electron compensator: an analysis of printing parameters

BİLTEKİN F., YAZICI G., ÖZYİĞİT G.

ESTRO 2021, Madrid, Spain, 28 - 31 August 2021, vol.161, pp.1347-1348, (Summary Text)

9. PO-1583 3D In-vivo dosimetry for preclinical dose verification of small animal irradiation: a phantom study

BİLTEKİN F., ÖZYİĞİT G.

ESTRO 2021, Madrid, Spain, 28 - 31 August 2021, vol.161, pp.1307-1309, (Summary Text)

10. PO-1624 Dose Response characteristics and ghosting effect analysis for 3D EPID in-vivo dosimetry system

BİLTEKİN F., ÖZYİĞİT G.

ESTRO 2021, Madrid, Spain, 28 - 31 August 2021, vol.161, pp.1345-1346, (Summary Text)

11. PH-0600 3D in-vivo dosimetry for detecting interplay effect: a phantom study

BİLTEKİN F., ÖZYİĞİT G.

ESTRO 2021, Madrid, Spain, 28 - 31 August 2021, vol.161, pp.464-466, (Summary Text)

12. PO-1633 EPID-based 3D in vivo dosimetry in head and neck radiotherapy

BİLTEKİN F., YAZICI G., ÖZYİĞİT G.

ESTRO 2021, Madrid, Spain, 28 - 31 August 2021, vol.161, pp.1354-1355, (Summary Text)

13. Treatment outcomes of metastasis-directed treatment using 68 Ga-PSMA-PET/CT for oligometastatic or oligorecurrent prostate cancer: Turkish Society for Radiation Oncology group study (TROD 09-002)

HÜRMÜZ P., ÖNAL H. C., ÖZYİĞİT G., İĞDEM M. Ş., ATALAR B., sayan h., et al.

Türk Radyasyon Onkolojisi sanal Kongresi, Turkey, 20 - 22 November 2020, (Summary Text) Sustainable Development

14. Gleason skoru 10 prostat kanserierinde definif radyoterapi ve ADT sonuçları: TROD09-001 ÜRO- ONKOLOJİ GRUBU ÇALıŞMASI

HÜRMÜZ P., ÖNAL H. C., İribaş A., ALSAN ÇETİN İ., Akbulut S., GÖRKEN İ., et al.

Türk radyasyon onkolojisi derneği sanal kongre, Turkey, 20 - 22 November 2020, (Full Text) Sustainable Development

15. Importance of Parotid Stem Cells in Xerostomia after Head and Neck Radiotherapy

YÜCE SARI S., ELMALI A., YILMAZ M. T., YEDEKÇİ F. Y., YÜCE D., ÖZYİĞİT G., et al.

ASTRO 2020, United States Of America, 24 - 28 October 2020, vol.108, pp.723-724, (Summary Text)

16. Interpreting Clinical Parameters and Nomograms for Predicting Lymph Node Metastasis Detected with 68 Ga-PSMAPET/CT in prostate cancer patients

ÖNAL H. C., ÖZYİĞİT G., Oymak E., GÜLER O. C., HÜRMÜZ P., TİLKİ B., et al.

62nd Annual Meeting of the American-Society-for-Radiation-Oncology (ASTRO), 25 October - 28 December 2020, (Summary Text) Sustainable Development

17. Definitive Chemoradiotherapy in Esophageal Squamous Cell Cancer: A Single Center Experience

YILMAZ M. T., HÜRMÜZ P., CENGİZ M., YÜCE D., ZORLU A. F., AKYOL H. F., et al.

9th International Gastrointestinal Cancer Conference, İstanbul, Turkey, 6 - 08 December 2019 Sustainable Development

18. the role of neoadjuvant radiotherapy in rectal cancer: hacettepe university experience

HÜRMÜZ P., TİLKİ B., YILDIZ F., ÖZYİĞİT G., EROL T., KONAN A., et al.

9th international gastrointestinal cancer conference, 6 - 08 December 2019, (Full Text) Sustainable Development

19. DEFİNİTİVE CHEMORADİOTHERAPY İN ESOPHAGEAL S@UAMOUS CELL CANCER A SİNGLE CENTER EXPERİENCE

HÜRMÜZ P., CENGİZ M., YÜCE D., ZORLU A. F., AKYOL H. F., YALÇIN Ş., et al.

9 th international gastrointestinal cancer conference, 6 - 08 December 2019, (Full Text) Sustainable Development

20. non-operative management of rectal cancer: hacettepe university experience

TİLKİ B., HÜRMÜZ P., CENGİZ M., ZORLU A. F., ÖZYİĞİT G., YILDIZ F., et al.

9th international gastrointestinal cancer conference, 6 - 08 December 2019, (Full Text) Sustainable Development

21. The Role of Radiotherapy /- Chemotherapy in the treatment of Rectal Cancer: Single Center Experience

TİLKİ B., HÜRMÜZ P., CENGİZ M., YILDIZ F., ZORLU A. F., ÖZYİĞİT G., et al.

6th CONGRESS OF THEMEDITERRANEAN MULTIDISCIPLINARY ONCOLOGY FORUM3rd INTERNATIONAL CONGRESS ON ONCOLOGICAL SCIENCES, 27 November - 01 December 2019, vol.5, (Full Text) Sustainable Development

22. Gemcitabine Based Trimodality Treatment in Patients WithMuscle Invasive Bladder Cancer: Hacettepe University Experience

Esen Ç. S. B., HÜRMÜZ P., KILIÇKAP S., ÖZYİĞİT G., AKYOL H. F.

6th CONGRESS OF THEMEDITERRANEAN MULTIDISCIPLINARY ONCOLOGY FORUM3rd INTERNATIONAL CONGRESS ON ONCOLOGICAL SCIENCES, 27 November - 01 December 2019, vol.5, (Full Text) Sustainable Development

23. A Single Center Experience of Neoadjuvant Radiotherapy in Rectal Cancer

HÜRMÜZ P., TİLKİ B., CENGİZ M., YILDIZ F., ÖZYİĞİT G., EROL T., et al.

6th CONGRESS OF THEMEDITERRANEAN MULTIDISCIPLINARY ONCOLOGY FORUM3rd INTERNATIONAL CONGRESS ON ONCOLOGICAL SCIENCES, 27 November - 01 December 2019, vol.5, (Full Text) Sustainable Development

24. Does Intravesical Prostatic Protrusion Effect Oncological Outcome And Toxicity In Prostate Cancer Patients Who Underwent Definitive Radiotherapy?

Esen Ç. S. B., HÜRMÜZ P., ÜNAL E., Karçaaltıncaba M., AKYOL H. F., ÖZYİĞİT G.

6th CONGRESS OF THEMEDITERRANEAN MULTIDISCIPLINARY ONCOLOGY FORUM3rd INTERNATIONAL CONGRESS ON ONCOLOGICAL SCIENCES, 27 November - 01 December 2019, (Full Text) Sustainable Development

25. Results of Reirradiation with Stereotactic Radiotherapy in Recurrent Head and Neck Cancer

YÜCE SARI S., CENGİZ M., ELMALI DOĞAN A., YILMAZ M. T., YAZICI G., ÖZYİĞİT G.

ASTRO 2019, 15 - 18 September 2019, (Summary Text) Sustainable Development

26. The Role of (68)ga-PSMA-PET/CT in Pelvic FIELD Delineation in Prostate Cancer Patients with Pelvic Lymph Node Metastasis

Onal C., HÜRMÜZ P., Torun N., TUNCEL M., Guler O. C., Reyhan M., et al.

61st Annual Meeting of the American-Society-for-Radiation-Oncology (ASTRO), Illinois, United States Of America, 15 - 18 September 2019, vol.105, (Summary Text)

27. Investigation of Electronic Portal Imaging Based In-Vivo Dose Verification for Prostate SBRT

BİLTEKİN F., YEDEKÇİ F. Y., ÖZYİĞİT G.

ESTRO 38, 26-30 April 2019, Milan, Italy, Mılano, Italy, 26 April 2019, pp.956-957, (Full Text)

28. A Feasibility Study of EPID-Based In-Vivo Dosimetry System in Machine Specific Quality Assurance

YEDEKÇİ F. Y., BİLTEKİN F., ÖZYİĞİT G.

ESTRO 38, Mılano, Italy, 26 April 2019, pp.955, (Full Text)

29. Castrate testosterone predicts biochemical relapse free survival in non-metastatic prostate cancer

ÖZYİĞİT G., HÜRMÜZ P., YÜCE D., AKYOL H. F.

38th Annual Meeting of the European-Society-for-Radiotherapy-and-Oncology (ESTRO), 26 - 30 April 2019, vol.133, pp.440, (Summary Text) Sustainable Development

30. Stereotactic Body Radiotherapy in Prostate Cancer: A Single Center Experience

AKYOL H. F., HÜRMÜZ P., YÜCE SARI S., Doğan Elmalı A., YÜCE D., YAZICI M. S., et al.

38th Annual Meeting of the European-Society-for-Radiotherapy-and-Oncology (ESTRO), 24 - 30 April 2019, vol.133, pp.828, (Full Text) Sustainable Development

31. Metastases directed SBRT using Ga68-PSMA for oligometastatic prostate cancer: TROD 09-002 Study

ÖZYİĞİT G., İĞDEM M. Ş., ATALAR B., ÖZKÖK H. B., HÜRMÜZ P., AKYOL H. F.

38th Annual Meeting of the European-Society-for-Radiotherapy-and-Oncology (ESTRO), 26 - 30 April 2019, vol.133, pp.827-828, (Summary Text) Sustainable Development

32. EP-1770 Investigation of Electronic Portal Imaging Based In-Vivo Dose Verification for Prostate SBRT

BİLTEKİN F., YEDEKÇİ F. Y., ÖZYİĞİT G.

ESTRO 38, Milan, Italy, 26 - 30 April 2019, vol.133, pp.956-957, (Summary Text)

33. EP-1768 A Feasibility Study of EPID-Based In-Vivo Dosimetry System in Machine Specific Quality Assurance

YEDEKÇİ F. Y., BİLTEKİN F., ÖZYİĞİT G.

ESTRO 38, Milan, Italy, 26 April 0219 - 30 April 2019, vol.133, pp.955, (Summary Text)

34. Meme Kanserinde Mammaria İnterna Işınlaması ile İnternal Mammarian Arterdeki Değişikliklerin Bilgisayarlı Tomografideki Korelasyonu.

DURHAN G., ERDEMİR A. G., YÜCE SARI S., GÜLTEKİN M., KARAKAYA KARABULUT J., GÜLSÜN AKPINAR M., et al.

Ulusal Kanser Kongresi, Turkey, 17 - 21 April 2019 Sustainable Development

35. Meme Kanserli Olgularda Prognostik Evreleme Sisteminin Değerlendirilmesi.

BEDÜK Ç. S., YILMAZ M. T., YÜCE D., YÜCE SARI S., GÜLTEKİN M., ÖZYİĞİT G., et al.

Ulusal Kanser Kongresi, Turkey, 17 - 21 April 2019, (Full Text) Sustainable Development

36. Application of Extended CT Scale and Metal Artefact Reduction Methods on Radiotherapy Planning

Yucel H., BİLTEKİN F., ÖZYİĞİT G., YAZICI G.

38th Annual Meeting of the European-Society-for-Radiotherapy-and-Oncology (ESTRO), Milan, Italy, 26 - 30 April 2019, vol.133, (Summary Text)

37. Quality assurance of micro-MLC based IMRT plans using patient-specific phantom

Sunel S., YEĞİNER M., Akyol F., BİLTEKİN F., ÖZYİĞİT G.

38th Annual Meeting of the European-Society-for-Radiotherapy-and-Oncology (ESTRO), Milan, Italy, 26 - 30 April 2019, vol.133, (Summary Text)

38. The outcome of loco-regional radiotherapy in metastatic castration-resistant prostate cancer patients treated with abiraterone acetate.

Yildirim B., Cem O., Kose F., Oymak E., Sedef A. M., Besen A. A., et al.

ASCO-SITC Clinical Immuno-Oncology Symposium, San-Francisco, Costa Rica, 28 February - 02 March 2019, vol.37, (Summary Text) Sustainable Development

39. The hematologic parameters in metastatic castration-resistant prostate cancer patients treated with abiraterone acetate.

Cem O., Sedef A. M., Kose F., Oymak E., Guler O. C., Sumbul A. T., et al.

ASCO-SITC Clinical Immuno-Oncology Symposium, San-Francisco, Costa Rica, 28 February - 02 March 2019, vol.37, (Summary Text) Sustainable Development

40. Evre II Endometrium Kanserli Olgularda Eksternal Radyoterapi VE Kaf Brakiterapisi Uygulanmasının Hastalık Kontrolüne Etkisi.

YÜCE SARI S., GÜLTEKİN M., ÖZGÜL N., YÜCE K., AYHAN A., ÖZYİĞİT G., et al.

1. ULUSLARARASI VE 16. ULUSAL JİNEKOLOJİK ONKOLOJİ KONGRESİ, 21 - 25 November 2018, (Full Text) Sustainable Development

41. Kötü Histolojili Endometrium Kanserli Olgularda Yalnız Vajen Kaf Brakiterapisi Uygulamasının Sonuçlar

GÜLTEKİN M., YÜCE SARI S., SALMAN M. C., ALTUNDAĞ Ö., TÜRKER F. A., KARS S. A., et al.

1. ULUSLARARASI VE 16. ULUSAL JİNEKOLOJİK ONKOLOJİ KONGRESİ, 21 - 25 November 2018, (Full Text) Sustainable Development

42. ESMO-ESGO-ESTRO Risk Gruplamasına Göre Endometrium Kanserli Olgularda Sağkalım ve Rekürrens

YÜCE SARI S., GÜLTEKİN M., RAHATLI S., ALTUNDAĞ Ö., TÜRKER F. A., KARS S. A., et al.

1. ULUSLARARASI VE 16. ULUSAL JİNEKOLOJİK ONKOLOJİ KONGRESİ, 21 - 25 November 2018, (Full Text) Sustainable Development

43. Patterns of Recurrence and Survival Rates in Endometrial Cancer According to ESMO-ESGO-ESTRO Risk Classification

YÜCE SARI S., GÜLTEKİN M., RAHATLI S., ALTUNDAĞ Ö., TÜRKER F. A., KARS S. A., et al.

2018 ASTRO Annual Meeting, San-Antonio, Northern Mariana Islands, 15 - 18 November 2018, vol.102, pp.648, (Full Text) Sustainable Development

44. Inverse Planning Intensity-Modulated Radiation Therapy in Chest Wall and Lymphatic Irradiation: Early Results

BEDÜK ESEN S., YILMAZ M. T., YEDEKÇİ F. Y., YÜCE SARI S., GÜLTEKİN M., ÖZYİĞİT G., et al.

60th Annual Meeting of the American Society for Therapeutic Radiology and Oncology, 21 - 24 October 2018, (Full Text)

45. Patterns of Recurrence and Survival Rates in Endometrial Cancer According to ESMO-ESGO-ESTRO Risk Classification.

YÜCE SARI S., GÜLTEKİN M., RAHATLI S., ALTUNDAĞ Ö., TÜRKER F. A., KARS S. A., et al.

60th Annual Meeting of the American Society for Therapeutic Radiology and Oncology, 21 - 24 October 2018, (Full Text) Sustainable Development

46. Integration of (68)ga-PSMA-PET/BT in Radiation Therapy Planning for Prostate Cancer Patients: A Multi-Institutional Analysis

Onal C., Torun N., HÜRMÜZ P., Guler O. C., TUNCEL M., Yildirim B. A., et al.

60th Annual Meeting of the American-Society-for-Radiation-Oncology (ASTRO), San-Antonio, Northern Mariana Islands, 21 - 24 October 2018, vol.102, (Summary Text)

47. Impact of External Radiotherapy /- Vaginal Cuff Brachytherapy on Disease Control in Patients with Stage II Endometrial Cancer

YÜCE SARI S., GÜLTEKİN M., ÖZGÜL N., YÜCE K., AYHAN A., ÖZYİĞİT G., et al.

IGCS 2018, 14 - 16 September 2018, (Summary Text) Sustainable Development

48. Uncertainties in the Delineation of 3-Dimensional Brachytherapy of Cervical Cancer

ELMALI DOĞAN A., GÜLTEKİN M., YÜCE SARI S., BİLTEKİN F., YÜCE D., ÖZYİĞİT G., et al.

IGCS 2018, 14 - 16 September 2018, (Summary Text) Sustainable Development

49. Results of Vaginal Cuff Brachytherapy Alone for the Treatment of Endometrial Cancer with Adverse Histopathology

GÜLTEKİN M., YÜCE SARI S., SALMAN M. C., ALTUNDAĞ Ö., TÜRKER F. A., KARS S. A., et al.

IGCS 2018, 14 - 16 September 2018, (Summary Text) Sustainable Development

50. YOĞUNLUK AYARLI RADYOTERAPİDE DOZ HIZININ DOZ DAĞILIMINA ETKİSİ

YEDEKÇİ F. Y., GÜRKAYNAK H. M., ÖZYİĞİT G.

13. ULUSAL RADYASYON ONKOLOJİSİ KONGRESİ, BAFRA, Cyprus (Kktc), 27 April 2018, (Summary Text)

51. KEMİĞİN İNORGANİK BİLEŞENİ HİDROKSİAPATİTLERE UYGULANAN RADYASYONUN RADYOTERAPİYE BAĞLI KEMİK KIRIKLARINA ETKİSİ

YEDEKÇİ F. Y., EVİS Z., GÜRKAYNAK H. M., ÖZYİĞİT G.

Ulusal Radyasyon Onkolojisi Kongresi, BAFRA, Cyprus (Kktc), 27 April 2018, (Summary Text)

52. Metastatik NUT Midline Karsinomunda İmmünoterapi ve Reirradyasyon: Vaka Sunumu.

ELMALI DOĞAN A., YILMAZ M. T., AKSOY S., YÜCE SARI S., ÖZYİĞİT G., YAZICI G.

13.Ulusal Radyasyon Onkolojisi Kongresi, Turkey, 27 April - 01 May 2018, (Full Text)

53. Adjuvan Yoğunluk Ayarlı Radyoterapi Uygulanan Baş-Boyun Kanserli Olgularda Tedavi Sonuçlarımız.

YÜCE SARI S., CENGİZ M., YAZICI G., ELMALI DOĞAN A., BEDÜK Ç. S., GÜLLÜ İ. H., et al.

13.Ulusal Radyasyon Onkolojisi Kongresi, Turkey, 27 April - 01 May 2018, (Full Text) Sustainable Development

54. Evre II Endometrium Kanserli Olgularda Eksternal Radyoterapi /- Kaf Brakiterapisi Uygulanmasının Hastalık Kontrolüne Etkisi

YÜCE SARI S., GÜLTEKİN M., ÖZGÜL N., YÜCE K., AYHAN A., ÖZYİĞİT G., et al.

13. ULUSAL RADYASYON ONKOLOJİSİ KONGRESİ, Turkey, 27 April - 01 May 2018, (Full Text) Sustainable Development

55. Prostat Kanserli Olgularda Postoperatif Radyoterapi Sonuçlarımız

AKYOL H. F., HÜRMÜZ P., YÜCE SARI S., BEDÜK Ç. S., KAVAK G., ÖZYİĞİT G.

13. ULUSAL RADYASYON ONKOLOJİSİ KONGRESİ, Turkey, 27 April - 01 May 2018, (Full Text) Sustainable Development

56. Göğüs Duvarı ve Lenfatik Işınlamada Ters Planlamalı Yoğunluk Ayarlı Radyoterapi: Erken Dönem Sonuçlar.

BEDÜK Ç. S., YILMAZ M. T., YEDEKÇİ F. Y., YÜCE SARI S., GÜLTEKİN M., ÖZYİĞİT G., et al.

13. UROK, Turkey, 27 April - 01 May 2018

57. Erken Evre Akciğer Kanserlerinde Uygulanan Stereotaktik Ablatif Beden Radyoterapisinin Hedef Doz Yanıtı ve Toksisite Sonuçlarının Fiziksel Olarak Değerlendirilmesi

akbayırlı u., YÜCE SARI S., ÖZYİĞİT G.

13. UROK, Turkey, 27 April - 01 May 2018 Sustainable Development

58. Baş-Boyun Melanomlarında Radyoterapi Sonuçlarımız

YÜCE SARI S., YAZICI G., CENGİZ M., YILMAZ M. T., AKSOY S., GÜLLÜ İ. H., et al.

13. ULUSAL RADYASYON ONKOLOJİSİ KONGRESİ, Turkey, 27 April - 01 May 2018, (Full Text)

59. Kötü Histolojili Endometrium Kanserli Olgularda Yalnız Vajen Kaf Brakiterapisi Uygulamasının Sonuçları

GÜLTEKİN M., YÜCE SARI S., SALMAN M. C., ALTUNDAĞ Ö., TÜRKER F. A., KARS S. A., et al.

13. ULUSAL RADYASYON ONKOLOJİSİ KONGRESİ, Turkey, 27 April - 01 May 2018 Sustainable Development

60. 3D Performance Analysis of Cyberknife Synchrony® Respiratory Tracking System

ŞAHİN M. C., HÜRMÜZ P., YEĞİNER M., YAZICI G., ÖZYİĞİT G.

ESTRO 36, 5 - 09 May 2017, vol.123, pp.149, (Summary Text)

61. Adenoid Kistik Karsinomlu Olgularda Radyoterapi Sonuçları: Türk Radyasyon Onkolojisi Grubu Çalışması

ÖZYİĞİT G., AKMANSU M., YÜCE SARI S., ERPOLAT Ö. P., DİZMAN A., ATASOY B. M., et al.

22. UKK, Turkey, 19 - 23 April 2017, (Summary Text)

62. Adenoid ksitik karsinomlu olgularda radyoterapi sonuçları: Türk Radyasyon Onkolojisi Grubu Çalışması

ÖZYİĞİT G., AKMANSU M., YÜCE SARI S., ERPOLAT Ö. P., Dizman A., ATASOY B. M., et al.

22. Ulusal Kanser Kongresi, Turkey, 19 - 23 April 2017, (Summary Text)

63. Rekürren Baş-Boyun Kanserli Olgularda Stereotaktik Radyoterapi ile Reirradyasyon Sonuçları ve Karotis Blow-Out Sendromu: Türk Radyasyon Onkolojisi Grubu Çalışması

CENGİZ M., ÖZYAR E., YÜCE SARI S., ŞAHİN B., YAZICI G., ÖZYİĞİT G.

22. ULUSAL KANSER KONGRESİ, Turkey, 19 - 23 April 2017, (Summary Text) Sustainable Development

64. Definitif Radyoterapi Uygulanan Lokal İleri Evre Larinks Kanserli Hastalarda Hematolojik Parametrelerin Sağkalım Üzerine Prognostik Etkisi

YÜCE SARI S., CENGİZ M., GÜLTEKİN M., SÜSLÜ N., YAZICI G., HAYRAN K. M., et al.

22. UKK, Turkey, 19 - 23 April 2017, (Summary Text) Sustainable Development

65. AKCİĞER KANSERLERİNDE STEREOTAKTİK ABLATİF BEDEN RADYOTERAPİSİNİN TOKSİSİTE VE DOZ YANIT İLİŞKİSİNİN MATEMATİKSEL MODEL İLE GÖRÜNTÜ VE DOZİMETRİK ANALİZİ

AKBAYIRLI U., YÜCE SARI S., AKYOL H. F., YEĞİNER M., ÖZYİĞİT G.

22. UKK, Turkey, 19 - 23 April 2017, (Summary Text) Sustainable Development

66. Cyberknife Synchrony® Solunum Takip Sisteminin Polimer Jel Dozimetre İle Üç Boyutlu Performans Analizi

Şahin M. C., HÜRMÜZ P., YEĞİNER M., ÖZYİĞİT G.

22. UKK, Turkey, 19 - 23 April 2017, (Summary Text)

67. Two-Dimensional Array-Based Mechanical Quality Control of High-Dose-Rate Brachytherapy Treatment Unit

BİLTEKİN F., YEĞİNER M., DOĞAN A., GÜLTEKİN M., ÖZYİĞİT G., YILDIZ F.

58th Annual Meeting of the American-Society-for-Radiation-Oncology (ASTRO), Massachusetts, United States Of America, 25 - 28 September 2016, vol.96, (Summary Text)

68. Concurrent Trastuzumab Use with Radiotherapy and the Risk for Cardiotoxicity

YÜCE SARI S., YAZICI G., ŞENDUR M. A. N., ALTUNDAĞ K., GÜLTEKİN M., YILDIZ F., et al.

ASTRO 2016 ANNUAL MEETING, BOSTON, United States Of America, 25 - 28 September 2016, (Summary Text)

69. Radiotherapy Outcomes after Skin Sparing Mastectomy and Implant Based Breast Reconstruction

YÜCE SARI S., KÖTEK A., GÜLTEKİN M., AKKUŞ YILDIRIM B., ÖNAL H. C., ÖZYİĞİT G., et al.

ASTRO 2016 ANNUAL MEETING, BOSTON, United States Of America, 25 - 28 September 2016, (Summary Text)

70. Survival and Larynx Preservation Rates after Definitive Radiotherapy A Single Center Experience

CENGİZ M., YÜCE SARI S., GÜLTEKİN M., SÜSLÜ N., AKSOY S., KUŞCU O., et al.

ECHNO 2016, Budapest, Hungary, 7 - 10 September 2016, (Summary Text)

71. The Role of Fractionated Stereotactic Radiotherapy in the Primary Treatment of Optic Glioma and Meningioma

YÜCE SARI S., YAZICI G., ÖZYİĞİT G., ÖZGEN MOCAN B., CENGİZ M., ZORLU A. F.

RADIOSURGERY SOCIETY MEETING 2016, ORLANDO, United States Of America, 16 - 18 June 2016, (Summary Text)

72. Radiotherapy is as Effective as Surgery in terms of Local Control in Patients with Uveal Melanoma

YAZICI G., ÖZYİĞİT G., YÜCE SARI S., KIRATLI H., CENGİZ M., ZORLU A. F.

RADIOSURGERY SOCIETY MEETING 2016, ORLANDO, United States Of America, 16 - 18 June 2016, (Summary Text)

73. Results of Reirradiation with Stereotactic Radiotherapy in Recurrent Head and Neck Cancer

YÜCE SARI S., CENGİZ M., YAZICI G., ÖZYİĞİT G., kıvanç h., YILDIZ D., et al.

RADIOSURGERY SOCIETY MEETING 2016, ORLANDO, United States Of America, 16 - 18 June 2016, (Summary Text) Sustainable Development

74. Optik Gliom ve Menenjiom Tanılı Olguların Primer Tedavisinde Fraksiyone Stereotaktik Radyoterapinin Yeri

YÜCE SARI S., YAZICI G., ÖZYİĞİT G., ÖZGEN MOCAN B., CENGİZ M., ZORLU A. F.

9. MULTİDİSİPLİNER NÖROONKOLOJİ SEMPOZYUMU, İstanbul, Turkey, 13 - 14 May 2016, (Summary Text)

75. Optik gliom ve menenjiom tanılı olguların primer tedavisinde fraksiyone stereotaktik radyoterapinin yeri

YÜCE SARI S., YAZICI G., ÖZYİĞİT G., ÖZGEN MOCAN B., CENGİZ M., ZORLU A. F.

12. UROK, Turkey, 20 - 24 April 2016, (Summary Text)

76. Evre IIIC endometrium kanserli olgularda tedavi sonuçlarımız

YÜCE SARI S., GÜLTEKİN M., ÖZYİĞİT G., YILDIZ F.

12. UROK, Turkey, 20 - 24 April 2016, (Summary Text) Sustainable Development

77. Yaşlı meme kanserli hastalarda tedavi sonuçları ve prognostik faktörler TROD Meme Kanseri Grubu çalışma sonuçları

ERPOLAT Ö. P., YÜCE SARI S., AKKUŞ YILDIRIM B., GÜLTEKİN M., ÖNAL H. C., YAVAŞ G., et al.

12. UROK, Turkey, 20 - 24 April 2016, (Summary Text) Sustainable Development

78. Genç ve yaşlı meme kanserli hastaların karşılaştırılması TROD Meme Kanseri Çalışma Grubu sonuçları

ERPOLAT Ö. P., YÜCE SARI S., akkuş yıldırım b., GÜLTEKİN M., ARICAN ALICIKUŞ L. Z., ÖNAL H. C., et al.

12. UROK, Turkey, 20 - 24 April 2016, (Summary Text) Sustainable Development

79. Genç meme kanserli hastalarda tedavi sonuçları ve prognostik faktörler TROD Meme Kanseri Grubu çalışma sonuçları

ERPOLAT Ö. P., YÜCE SARI S., AKKUŞ YILDIRIM B., GÜLTEKİN M., ARICAN ALICIKUŞ L. Z., ÖNAL H. C., et al.

12. UROK, Turkey, 20 - 24 April 2016, (Summary Text) Sustainable Development

80. Radyoterapi ile eş zamanlı trastuzumab kullanımı ve kardiyotoksisite etkisi

YÜCE SARI S., YAZICI G., ŞENDUR M. A. N., ALTUNDAĞ K., GÜLTEKİN M., YILDIZ F., et al.

12. UROK, Turkey, 20 - 24 April 2016, (Summary Text)

81. Cilt koruyucu mastektomi ve implant temelli rekonstrüksiyon sonrası radyoterapi sonuçlarımız

YÜCE SARI S., kötek a., GÜLTEKİN M., akkuş yıldırım b., ÖNAL H. C., ÖZYİĞİT G., et al.

12. UROK, Turkey, 20 - 24 April 2016, (Summary Text)

82. Neoadjuvan Kemoterapi Uygulanan Meme Kanserli Olgularda Sonuçlarımız

ALANYALI S., YÜCE SARI S., GÜLTEKİN M., ÇOLPAN ÖKSÜZ D., ERPOLAT Ö. P., YAVAŞ G., et al.

12. UROK, Turkey, 20 - 24 April 2016, (Summary Text) Sustainable Development

83. Meme Radyoterapisi Uygulanan Hastalarda Günlük Tedavi Öncesi ve Sonrası Alınan Portal Görüntülerin Karşılaştırılması

TANRISEVEN K., KAYACI F., GÜLTEKİN M., YÜCE SARI S., YILDIZ F., ÖZYİĞİT G.

12. UROK, Turkey, 20 - 24 April 2016, (Summary Text)

84. GAMMAMED Plus HDR Brakiterapi Cihazında Gün İçerisindeki Aktivite Değişiminin Tedavi Dozuna Etkisinin İncelenmesi

BİLTEKİN F., DOĞAN A., YEĞİNER M., Ünlü B., GÜLTEKİN M., ÖZYİĞİT G., et al.

12. Ulusal Radyasyon Onkolojisi Kongresi, Turkey, 20 April 2016, (Summary Text)

85. YART de Yaprak Hareketleri Tekrarlanabilirliğinin DAVID In Vivo Dozimetri Sistemi ve Dynalog Dosyaları İle İncelenmesi

Karagöz Güray G., ZORLU A. F., YEĞİNER M., YILDIZ D., ÖZYİĞİT G.

12. Ulusal Radyasyon Onkolojisi Kongresi, Turkey, 20 April 2016, (Summary Text)

86. 3 Boyutlu Brakiterapi Uygulamalarında Aplikatör Pozisyon Farklılıklarının Tedavi Planlamasına Etkisinin İncelenmesi

BİLTEKİN F., GÜLTEKİN M., Ünlü B., YEĞİNER M., DOĞAN A., ÖZYİĞİT G., et al.

12. Ulusal Radyasyon Onkolojisi Kongresi, Turkey, 20 April 2016, (Summary Text)

87. HDR Brakiterapi Cihazının Mekanik Kontrol Testlerinde 2D Array İyon Odasının Kullanabilirliğinin Test Edilmesi

BİLTEKİN F., YEĞİNER M., DOĞAN A., Ünlü B., GÜLTEKİN M., ÖZYİĞİT G., et al.

12. Ulusal Radyasyon Onkolojisi Kongresi, Turkey, 20 April 2016, (Summary Text)

88. Radiation Therapy Results of Patients With Adenoid Cystic Carcinoma

GÜLTEKİN M., CENGİZ M., Sari S. Y., HOŞAL Ş., YAZICI G., SÜSLÜ N., et al.

57th Annual Meeting of the American-Society-for-Radiation-Oncology (ASTRO), San-Antonio, Northern Mariana Islands, 18 - 21 October 2015, vol.93, (Summary Text)

89. Hypofractionated Stereotactic Radiation Therapy/Radiosurgery Results in Patients With Uveal Melanoma

YAZICI G., ÖZYİĞİT G., SARI S., TARLAN B., KIRATLI H., CENGİZ M., et al.

57th Annual Meeting of the American-Society-for-Radiation-Oncology (ASTRO), San-Antonio, Northern Mariana Islands, 18 - 21 October 2015, vol.93, (Summary Text)

90. Kranial ve ekstrakranial uygulamalarda robotik (Cyberknife®) ve linak tabanli (Novalis®) stereotaktik radyocerrahi/ radyoterapi sistemlerin dozimetrik olarak karşilaştirilmasi: tüm vücut dozu ve ikincil kanser riski değerlendirmesi

BİLTEKİN F., DURU BİRGİ S., EKEN S., YÜCEL H., GÜLTEKİN M., ÖZYİĞİT G., et al.

11. Ulusal Radyasyon Onkolojisi Kongresi, Antalya, Turkey, 23 - 27 April 2014, vol.29, pp.108-109, (Summary Text) Sustainable Development

91. Mikro MLC tabanlI dinamik YART uygulamalarında segment sayısının tedavi parametrelerine etkisinin incelenmesi

BİLTEKİN F., YÜCEL H., DURU BİRGİ S., EKEN S., YAZICI G., CENGİZ M., et al.

11. Ulusal Radyasyon Onkolojisi Kongresi, Antalya, Turkey, 23 - 27 April 2014, vol.29, pp.272-273, (Summary Text)

92. THE SECONDARY MALIGNANCY RISK ESTIMATION DUE TO THE NEUTRON CONTAMINATION IN 3D CRT AND IMRT TREATMENT TECHNIQUES

BİLTEKİN F., ÖZYİĞİT G., YEĞİNER M., CENGİZ M., ÇELİK D., YILDIZ F., et al.

Radiotherapy and Oncology, 01 May 2012, vol.103, pp.521-522, (Summary Text)

93. THE NEUTRON CONTAMINATION MEASUREMENT IN HIGH ENERGY ELECTRON BEAMS THERAPY

BİLTEKİN F., ÖZYİĞİT G., YEĞİNER M., YILDIZ D., CENGİZ M., YILDIZ F., et al.

Radiotherapy and Oncology, 01 May 2012, vol.103, pp.568, (Summary Text)

94. INVESTIGATING THE EFFECT OF WEDGE FILTER ON NEUTRON CONTAMINATION BY USING BUBBLE DETECTORS

BİLTEKİN F., ÖZYİĞİT G., YEĞİNER M., ÇELİK D., GÜRKAYNAK H. M.

Radiotherapy and Oncology, 01 May 2012, vol.103, pp.522, (Summary Text)

95. THE EVALUATION OF SECONDARY MALIGNANCY RISK DUE TO THE CRANIOSPINAL CT SIMULATION

BİLTEKİN F., Yüce Sarı S., YILDIZ D., ÇELİK D., Kasr Ghalion B., YEĞİNER M., et al.

Radiotherapy and Oncology, 01 May 2012, vol.103, pp.536, (Summary Text)

96. Parotis bezi tumorlerinin tedavisinde konvansiyonel, uc boyutlu konformal ve yogunluk ayarli radyoterapi tekniklerinin karsilastirilmasi

BİLTEKİN F., ÇELİK D., YÜREKLİ A. F., ŞİŞECİOĞLU S., GHALION B. K., ABDELKADER A., et al.

10. Ulusal Radyasyon Onkolojisi Kongresi, Turkey, 19 - 23 April 2012, (Summary Text)

97. Baş boyun Kanserlerinde Görüntü Kılavuzluğunda Radtoterapi Uygulamasında Portal Görüntüleme ile Tomografinin Karşılaştırılması

YAZICI G., Atamel M., YEĞİNER M., HÜRMÜZ P., GÜLTEKİN M., CENGİZ M., et al.

10. Ulusal Radyasyon Onkolojisi Kongresi 2012, Turkey, 19 April 2012, (Summary Text) Sustainable Development

98. Kama filtresinden kaynaklanan notron kontaminasyonunun esdeger doza katkisinin 18 MV medikal lineer hizlandiricida BD-PND bubble dedektor kullanilarak olculmesi

BİLTEKİN F., ÖZYİĞİT G., ÇOLAK Ş., ÇELİK D., AKYOL H. F., CENGİZ M., et al.

10. Ulusal Radyasyon Onkolojisi Kongresi, Antalya, Turkey, 19 - 23 April 2012, (Summary Text)

99. 18 MV foton enerjisinde 3B-KRT ve YART teknigi ile tedavi planlamasi yapilan prostat kanserli hastalarda notron kontaminasyonundan kaynakli ikincil kanser riskinin degerlendirilmesi

BİLTEKİN F., ÖZYİĞİT G., AKYOL H. F., ÇELİK D., YILDIZ F., ZORLU A. F., et al.

10. Ulusal Radyasyon Onkolojisi Kongresi, Antalya, Turkey, 19 - 23 April 2012, (Summary Text) Sustainable Development

100. Pelvik Tümörlerde Görüntü Kılavuzluğunda Radtoterapi Uygulamasında Portal Görüntüleme ile Tomografi Yöntemlerinin Karşılaştırılması

YAZICI G., Atamel M., YEĞİNER M., GÜLTEKİN M., HÜRMÜZ P., CENGİZ M., et al.

10. Ulusal Radyasyon Onkolojisi Kongresi, Turkey, 19 April 2012, (Summary Text)

101. 6 MV foton enerjisinde SRT/SRS ve YART uygulamalarindan kaynakli notron kontaminasyonunun dozimetrik olarak olculmesi

BİLTEKİN F., ÖZYİĞİT G., CENGİZ M., ÇELİK D., ZORLU A. F., YILDIZ F., et al.

10. Ulusal Radyasyon Onkolojisi Kongresi, Antalya, Turkey, 19 - 24 April 2012, (Summary Text)

102. 9 MeV, 10 MeV, 15 MeV ve 18 MeV elektron enerjilerinde BD-PND bubble dedektor kullanilarak notron kontaminasyonu olcumu

BİLTEKİN F., ÖZYİĞİT G., YILDIZ F., ÇELİK D., CENGİZ M., AKYOL H. F., et al.

10. Ulusal Radyasyon Onkolojisi Kongresi, Antalya, Turkey, 19 - 23 April 2012, (Summary Text)

103. Notron kontaminasyonundan kaynakli esdeger dozun alan boyutuna bagimliliginin dozimetrik olarak incelenmesi

BİLTEKİN F., ÖZYİĞİT G., ZORLU A. F., ÇELİK D., AKYOL H. F., CENGİZ M., et al.

10. Ulusal Radyasyon Onkolojisi Kongresi, Antalya, Turkey, 19 - 23 April 2012, (Summary Text)

104. Amorf Silikon yapıdaki Elektronik Portal Görüntüleme Cihazının EPID Yoğunluk Ayarlı Radyoterapi Tekniği YART için Gerekli olan Çok Yapraklı Kolimator ÇYK Testlerinde Film Yerine Kullanılabilirliliği

ÇELİK D., YILDIZ F., BİLTEKİN F., YEĞİNER M., AKYOL H. F., CENGİZ M., et al.

10. Ulusal Radyasyon Onkolojisi Kongresi, Turkey, 19 April 2012, (Summary Text)

105. Yogunluk ayarli radyoterapi (YART) teknigi ile tedavi edilen meme kanserli olgularda ikincil kanser riskinin degerlendirilmesi.

BİLTEKİN F., YÜCE SARI S., ŞİŞECİOĞLU M. S., YÜREKLİ A. F., GHALION B. K., ABDELKADER A., et al.

10. Ulusal Radyasyon Onkolojisi Kongresi, Antalya, Turkey, 19 - 23 April 2012, (Summary Text) Sustainable Development

106. Robotic Stereotactic Radiotherapy in Patients With Glomus Tumours

YAZICI G., ÖZYİĞİT G., CENGİZ M., HÜRMÜZ P., YÜCE SARI S., YILDIZ F., et al.

European Multidisciplinary Cancer Congress on Integrating Basic and Translational Science, Surgery, Radiotherapy, Medical oncology, Advocacy and Care, 23 - 27 September 2011, vol.47, (Full Text)

107. Comparison of FIGO 1988 and 2008 Classifications For Endometrial Carcinoma

ÖZYİĞİT G., GÜLTEKİN M., YILDIZ F., Beyaz H., HAYRAN K. M., Kose F., et al.

European Multidisciplinary Cancer Congress on Integrating Basic and Translational Science, Surgery, Radiotherapy, Medical oncology, Advocacy and Care, Stockholm, Sweden, 23 - 27 September 2011, vol.47, (Summary Text)

108. Glomus jugulare tümörlerinde robotik radyocerrahi erken dönem tedavi sonuçlarımız

ÖZYİĞİT G., CENGİZ M., YÜCE SARI S., YILDIZ F., GÜRKAYNAK H. M., AKYOL H. F., et al.

9. UROK, Turkey, 21 - 25 April 2010, (Summary Text)

Books 24

Metrics

Publication

262

Publication (WoS)

139

Publication (Scopus)

117

Citation (WoS)

816

H-Index (WoS)

Citation (Scopus)

633

H-Index (Scopus)

Citation (Scholar)

H-Index (Scholar)

Citation (TrDizin)

H-Index (TrDizin)

Citation (Sum Other)

Project

Thesis Advisory

Open Access

UN Sustainable Development Goals

Publications & Works